Skip to main content
MDLN
NASDAQ Finance

Stephen A. Schwarzman and Blackstone Entities Dispose of Over $1.14 Billion in Medline Inc. Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$41.07
Mkt Cap
$53.953B
52W Low
$38
52W High
$50.876
52W Position info
8.1% above low
Off High info
19% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

MDLN is trading near its 52-week low of $38 (8.1% above the low).

Summary

Stephen A. Schwarzman and Blackstone-affiliated 10% owners sold over $1.14 billion worth of Medline Inc. Class A Common Stock as part of a previously announced secondary offering.


Key Events · Ownership and Investor Activity · MDLN

  • Major 10% Owner Disposition

    Stephen A. Schwarzman and affiliated Blackstone entities, acting as 10% owners, disposed of Class A Common Stock totaling $1,143,314,217.

  • Participation in Secondary Offering

    These sales, which occurred on March 10, 2026, were part of the previously announced secondary offering of Medline Inc. shares.

  • Significant Share Reduction

    The disposition involved 27,852,986 shares through open market sales and an additional 366,337 shares via other acquisitions/dispositions, reflecting a notable reduction in their indirect holdings.


Analysis · MDLN · Finance

This Form 4 filing details a substantial disposition of Medline Inc. Class A Common Stock by Stephen A. Schwarzman and affiliated Blackstone entities, totaling over $1.14 billion. These sales, occurring on March 10, 2026, are part of the previously announced secondary offering. While the offering itself was public knowledge, this filing provides specific transaction details for a major 10% owner, confirming their participation in reducing their stake. The significant value of the shares sold, representing over 2% of the company's market capitalization, indicates a material reduction in holdings by these influential institutional investors. This follows a broader trend of private equity firms reducing their positions post-IPO, as evidenced by other concurrent filings reporting similar sales by Carlyle Group entities.

At the time of this filing, MDLN was trading at $41.07 on NASDAQ in the Finance sector, with a market capitalization of approximately $54B. The 52-week trading range was $38.00 to $50.88. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MDLN - Latest Insights

MDLN
Jul 09, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $40.85
Real-time Price: $38.75 info
Change: -$2.10 (-5%) info
Market Cap: $50.905B info
MDLN
Jul 08, 2026, 3:29 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $40.51
Real-time Price: $38.75 info
Change: -$1.76 (-4%) info
Market Cap: $50.905B info
MDLN
Jul 02, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $41.73
Real-time Price: $38.75 info
Change: -$2.98 (-7%) info
Market Cap: $50.905B info
MDLN
Jun 03, 2026, 9:36 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $33.37
Real-time Price: $38.75 info
Change: +$5.38 (+16%) info
Market Cap: $50.905B info
MDLN
Jun 02, 2026, 8:06 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $35.94
Real-time Price: $38.75 info
Change: +$2.81 (+8%) info
Market Cap: $50.905B info